{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:09:16Z","timestamp":1745467756064,"version":"3.40.4"},"reference-count":48,"publisher":"Media Sphere Publishing House","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rus. Ann. Ophthal."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Endocrine ophthalmopathy (EO; also called Graves\u2019 ophthalmopathy, thyroid eye disease) is a common extrathyroidal manifestation of Graves\u2019 disease, characterized by the presence of autoimmune inflammatory process in the orbital soft tissues. The prevalence of EO is approximately 10 cases per 10.000 population, higher in individuals over 50 years old. The pathogenesis of EO is primarily attributed to cross-reactive immune activity between thyroid antigens and orbital soft tissues. Clinically, EO may manifest as involvement of extraocular muscles or orbital fat depending on the affected area. Moderate, severe and very severe forms of EO in terms of disease compensation account for 4.9\u201410% of cases. For decades, glucocorticoid (GC) therapy has been the treatment of choice; however, up to 20% of EO patients are unresponsive to high-dose GC therapy, and about one-third experience early relapses after discontinuation. Polymorphisms in the glucocorticoid receptor gene NR3C1 have been implicated in GC resistance in patients with autoimmune diseases. However, studies, including clinical observations and genetic analyses, revealed no consistent patterns in the distribution of homozygous and heterozygous genotypes of polymorphic markers A6986G of the CYP3A5 gene, C&gt;T intron 6 of the CYP3A4 gene, and rs6190 of the NR3C1 gene, nor in their influence on GC response. These findings highlight the mechanisms underlying GC resistance in EO.<\/jats:p>","DOI":"10.17116\/oftalma2024140061125","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:49:26Z","timestamp":1735364966000},"page":"125","source":"Crossref","is-referenced-by-count":0,"title":["Glucocorticoid-resistant forms of endocrine ophthalmopathy"],"prefix":"10.17116","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-1952","authenticated-orcid":false,"given":"A.F.","family":"Brovkina","sequence":"first","affiliation":[{"name":"Russian Medical Academy of Continuous Professional Education","place":["Moscow, Russia"]},{"name":"Botkin Hospital","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2024140061125-1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14296"},{"key":"key-10.17116\/oftalma2024140061125-2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01479-z"},{"key":"key-10.17116\/oftalma2024140061125-3","doi-asserted-by":"publisher","DOI":"10.3275\/8937"},{"key":"key-10.17116\/oftalma2024140061125-4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993"},{"key":"key-10.17116\/oftalma2024140061125-5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0625-1"},{"key":"key-10.17116\/oftalma2024140061125-6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.12.6348"},{"key":"key-10.17116\/oftalma2024140061125-7","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2018.01.007"},{"key":"key-10.17116\/oftalma2024140061125-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.02.007"},{"key":"key-10.17116\/oftalma2024140061125-9","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2009.06.009"},{"key":"key-10.17116\/oftalma2024140061125-10","doi-asserted-by":"publisher","DOI":"10.1530\/JME-11-0006"},{"key":"key-10.17116\/oftalma2024140061125-11","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-019-00226-9"},{"key":"key-10.17116\/oftalma2024140061125-12","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01116-4"},{"key":"key-10.17116\/oftalma2024140061125-13","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14655"},{"key":"key-10.17116\/oftalma2024140061125-14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0716"},{"key":"key-10.17116\/oftalma2024140061125-15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952954"},{"key":"key-10.17116\/oftalma2024140061125-16","unstructured":"Brovkina AF, Yacenko OYu, Aubakirova AS. Characteristic of the orbital soft tissues in endocrine opthalmopathy by computer tomography. Oftal\u2019mologiya. 2006; 3(1):26-30 (In Russ.)"},{"key":"key-10.17116\/oftalma2024140061125-17","doi-asserted-by":"publisher","DOI":"10.17816\/OV25334"},{"key":"key-10.17116\/oftalma2024140061125-18","doi-asserted-by":"crossref","unstructured":"Petunina NA, Trukhina LV, Martirosian NS. Endocrine ophthalmopathy: state-of-the-art approaches. Problemyi endikrinologii. 2012;58(6):24-32 (In Russ.)","DOI":"10.14341\/probl201258624-32"},{"key":"key-10.17116\/oftalma2024140061125-19","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13524"},{"key":"key-10.17116\/oftalma2024140061125-20","unstructured":"Brovkina AF, Stoyukhina AS. Classification of endocrine ophthalmopathy. Problemyi endokrinologii. 2006;52(5):11-15 (In Russ.)"},{"key":"key-10.17116\/oftalma2024140061125-21","unstructured":"Brovkina AF. Endocrine ophthalmopathy. Oftal\u2019mologicheskie vedomosti. 2012;5(2):31-34 (In Russ.)"},{"key":"key-10.17116\/oftalma2024140061125-22","unstructured":"Brovkina AF, Yacenko OYu. Rationale for distinguishing the lipogenic form of thyroid orbitopathy. Russian Annals of Ophthalmology=Vestnik oftal\u2019mologii. 2013;129(2):28-32 (In Russ.)"},{"key":"key-10.17116\/oftalma2024140061125-23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3566"},{"key":"key-10.17116\/oftalma2024140061125-24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479"},{"key":"key-10.17116\/oftalma2024140061125-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.005"},{"key":"key-10.17116\/oftalma2024140061125-26","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30046-8"},{"key":"key-10.17116\/oftalma2024140061125-27","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2020.07.031"},{"key":"key-10.17116\/oftalma2024140061125-28","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15074"},{"key":"key-10.17116\/oftalma2024140061125-29","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3217_21"},{"key":"key-10.17116\/oftalma2024140061125-30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.785757"},{"key":"key-10.17116\/oftalma2024140061125-31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1962"},{"key":"key-10.17116\/oftalma2024140061125-32","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3235-z"},{"key":"key-10.17116\/oftalma2024140061125-33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910839"},{"key":"key-10.17116\/oftalma2024140061125-34","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0611"},{"key":"key-10.17116\/oftalma2024140061125-35","doi-asserted-by":"crossref","unstructured":"Saakyan SV, Panteleyeva OG, Batyrbekova FKh, Sirmays OS, Martirosyan NS, Petunina NA, Tsygankov AYu, Loginov VI, Burdenny AM. Genetic factors of glucocorticoid resistance in patients with Grave\u2019s ophthalmopathy. Effektivnaya farmakoterapiya. 2019;15(33):18-23 (In Russ.)","DOI":"10.33978\/2307-3586-2019-15-33-18-23"},{"key":"key-10.17116\/oftalma2024140061125-36","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2020136062125"},{"key":"key-10.17116\/oftalma2024140061125-37","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91475-2"},{"key":"key-10.17116\/oftalma2024140061125-38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.09.131"},{"key":"key-10.17116\/oftalma2024140061125-39","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.890686"},{"key":"key-10.17116\/oftalma2024140061125-40","unstructured":"Hu ZJ, He JF, Li KJ, Chen J, Xie XR. Decreased microRNA-146a in CD4+T cells promote ocular inflammation in thyroid-associated ophthalmopathy by targeting NUMB. Eur Rev Med Pharmacol Sci. 2017;21(8):1803-1809"},{"key":"key-10.17116\/oftalma2024140061125-41","doi-asserted-by":"publisher","DOI":"10.1159\/000464430"},{"key":"key-10.17116\/oftalma2024140061125-42","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4266(18)31239-3"},{"key":"key-10.17116\/oftalma2024140061125-43","unstructured":"Tong BD, Xiao MY, Zeng JX, Xiong W. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy. Mol Vis. 2015; 21:324-334"},{"key":"key-10.17116\/oftalma2024140061125-44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221077"},{"key":"key-10.17116\/oftalma2024140061125-45","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.19-27865"},{"key":"key-10.17116\/oftalma2024140061125-46","doi-asserted-by":"publisher","DOI":"10.25276\/2410-1257-2021-2-12-15"},{"key":"key-10.17116\/oftalma2024140061125-47","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310723"},{"key":"key-10.17116\/oftalma2024140061125-48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.10.025"}],"container-title":["Russian Annals of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:41:27Z","timestamp":1745397687000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/vestnik-oftalmologii\/2024\/6\/10042465X2024061125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12,28]]}},"alternative-id":["10.17116\/oftalma2024140061125"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2024140061125","relation":{},"ISSN":["0042-465X"],"issn-type":[{"type":"print","value":"0042-465X"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}